Table 2.

Study outcomes at 3 months.

	Total Cohort	Urban Residence	Rural Residence	P
CPAP use, h
All patients	3.19 (2.8–3.58), n = 242	3.25 (2.74–3.75), n = 142	3.08 (2.46–3.69), n = 100	.67
CPAP use > 0	4.89 (4.51–5.28), n = 157	4.80 (4.29–5.3), n = 96	5.04 (4.42–5.66), n = 61	.55
Adherent, n (%)	85 (35), n = 242	51 (36), n = 142	34 (34), n = 100	.76
Change in ESS	–2.5 (–3.2 to –1.8), n = 136	–2.3 (–3.2 to –1.4), n = 90	–2.8 (–4 to –1.7), n = 46	.47
Change in EQ-5D-3L	1.3 (–1.1 to 3.7), n = 137	–0.5 (–3.7 to 2.8), n = 89	4.6 (1.5–7.6), n = 48	.04
VSQ-9 total score	38 (37–39), n = 130	38 (37–39), n = 86	38 (36–40), n = 44	.90

Results are presented as mean (95% CI) unless otherwise indicated. CI = confidence interval, CPAP = continuous positive airway pressure, EQ-5D-3L = EuroQOL-5D 3-level visual analog score, ESS = Epworth Sleepiness Scale score, VSQ-9 = Visit-Specific Satisfaction Instrument.